StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)

Close on Nov 17, 2026Market cap $70.84MP/E –Yield –

Coya Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Coya Therapeutics's operating cash flow for the twelve months ending Sep 30, 2026 was -$21.83M. For fiscal 2025 it was -$10.74M. The highest annual figure on record is -$3.90M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.74M–
FY2024Dec 31, 2024-$10.29M–
FY2023Dec 31, 2023-$11.19M–
FY2022Dec 31, 2022-$7.24M–
FY2021Dec 31, 2021-$3.90M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$7.24M–
Q2 FY2026Jun 30, 2026-$7.38M–
Q1 FY2026Mar 31, 2026-$6.21M–
Q4 FY2025Dec 31, 2025-$1.01M–
Q3 FY2025Sep 30, 2025-$1.13M–
Q2 FY2025Jun 30, 2025-$5.77M–
Q1 FY2025Mar 31, 2025-$2.83M-231.8%
Q4 FY2024Dec 31, 2024-$2.41M–
Q3 FY2024Sep 30, 2024-$5.46M–
Q2 FY2024Jun 30, 2024-$4.56M–
Q1 FY2024Mar 31, 2024$2.15M–
Q4 FY2023Dec 31, 2023-$2.24M–
Q3 FY2023Sep 30, 2023-$2.22M–
Q2 FY2023Jun 30, 2023-$2.87M–
Q1 FY2023Mar 31, 2023-$3.86M–
Q4 FY2022Dec 31, 2022-$2.22M–
Q3 FY2022Sep 30, 2022-$1.59M–
Q2 FY2022Jun 30, 2022-$1.44M–
Q1 FY2022Mar 31, 2022-$1.98M–

More Coya Therapeutics figures

See a number that looks wrong?